Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Knee Bursitis Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for knee bursitis treatments experienced robust expansion recently, projecting a rise from $2.86 billion in 2025 to $3.06 billion in 2026, reflecting a compound annual growth rate of 7.3%. This historical growth trajectory is underpinned by several key factors: a surge in the occurrence of knee injuries and conditions resulting from repetitive strain, heightened engagement in athletic pursuits and physical fitness activities, the consistent utilization of diagnostic imaging for musculoskeletal issues, an increasing segment of the population entering older age groups with accompanying joint ailments, and the widespread accessibility of anti-inflammatory pharmaceuticals.

The market for knee bursitis treatments is poised for significant expansion over the coming years, projected to reach a value of $3.92 billion by 2030, with a compound annual growth rate of 6.4%. This anticipated growth is fueled by several key factors, including a heightened demand for less invasive medical procedures, a greater emphasis on identifying and preventing the condition early, a rise in the utilization of physiotherapy services, the expansion of facilities dedicated to orthopedic care, and enhanced accessibility to diagnostic imaging in developing economies. Dominating trends expected during this period are a growing inclination towards managing knee bursitis without surgery, the increased reliance on imaging technologies for precise diagnoses, a greater uptake of physical therapy and rehabilitation programs, the proliferation of outpatient and conservative treatment strategies, and heightened patient awareness concerning prompt management of knee injuries.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16460&type=smp

Knee Bursitis Market Expansion Drivers: What Is Shaping Future Growth?

The escalating incidence of skeletal ailments is anticipated to stimulate the expansion of the knee bursitis market in the foreseeable future. These bone-related conditions, including but not limited to osteoporosis, arthritis, and bone cancer, negatively impact the skeletal system’s structure, resilience, and functionality. A confluence of factors, such as an aging global population, predominantly sedentary lifestyles, suboptimal nutritional intake, and environmental shifts, contributes to the growing prevalence of these diseases. Conditions like osteoarthritis and rheumatoid arthritis can precipitate knee bursitis by inducing inflammation and excessive stress on the knee’s bursa. This inflammatory response subsequently leads to discomfort, swelling, and diminished joint mobility. To illustrate, data from Healthy Bones Australia, a non-profit entity dedicated to osteoporosis prevention and bone health awareness, indicated in October 2024 that approximately 6.2 million Australians aged 50 and above, representing about 67% of that demographic, suffered from compromised bone health. Projections suggest a substantial increase, with an estimated 7.7 million individuals expected to face osteopenia or osteoporosis by 2033. Consequently, the heightened prevalence of bone-related issues is a significant catalyst for the knee bursitis market’s growth.

The expanding demographic of individuals with diabetes is poised to invigorate the knee bursitis market’s progression

Knee Bursitis Market Segmentation And Category Breakdown

The knee bursitis market covered in this report is segmented –

1) By Diagnosis: Clinical Evaluation, Imaging Techniques, Laboratory And Procedural Tests, Differential Diagnosis Support

2) By Treatment: Medication, Therapy, Surgery, Other Treatments

3) By End User: Hospitals And Clinics, Diagnostic Centers, Research Centers, Academic Institutes, Other End Users

Subsegments:

1) By Clinical Evaluation: Medical History Assessment, Physical Examination

2) By Imaging Techniques: X-Ray, Ultrasound, Magnetic Resonance Imaging

3) By Laboratory And Procedural Tests: Bursa Fluid Aspiration, Blood Tests

4) By Differential Diagnosis Support: Infection Exclusion Tests, Inflammatory Marker Assessment, Trauma-Related Assessment

Knee Bursitis Market Competitive Analysis Of Major Industry Participants

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company, AbbVie Inc., Johnson & Johnson, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Stryker Corporation, Zimmer Biomet Holdings Inc., Arthrex Inc., Smith & Nephew plc, Medtronic plc, Exactech Inc., Conformis Inc., Bioventus LLC, Horizon Therapeutics plc, Amneal Pharmaceuticals Inc.

Access The Complete Knee Bursitis Market Report:

https://www.thebusinessresearchcompany.com/report/knee-bursitis-global-market-report

Knee Bursitis Market Largest Region By Revenue And Market Share

North Americawas the largest region in the knee bursitis market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model